Hansjoerg Riehm

The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence

Birgit Burkhardt, Martin Zimmermann, Ilske Oschlies et al. · British Journal of Haematology · 2005 · 336 citations

Medicine, Hematology, Pediatrics +16

Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System–Negative Stage III or IV Lymphoblastic Lymphoma

Birgit Burkhardt, Wilhelm Woessmann, Martin Zimmermann et al. · Journal of Clinical Oncology · 2006 · 158 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prevalence, Clinical Pattern, and Outcome of CNS Involvement in Childhood and Adolescent Non-Hodgkin's Lymphoma Differ by Non-Hodgkin's Lymphoma Subtype: A Berlin-Frankfurt-Münster Group Report

Janina Salzburg, Birgit Burkhardt, Martin Zimmermann et al. · Journal of Clinical Oncology · 2007 · 114 citations

Medicine, Oncology, Pediatrics +14

Vincristine (VCR) - Dexamethasone (DEXA) Pulses for Intermediate Risk (IR) Childhood Acute Lymphoblastic Leukemia (ALL) Treated with BFM Based Protocols: Results of the I-BFM-SG ALL IR 95 Study.

Valentino Conter, Maria Grazia Valsecchi, Daniela Silvestri et al. · Blood · 2005 · 16 citations

Medicine, Oncology, Pharmacology +14

Secondary Neoplasms Subsequent to Berlin-Frankfurt-Muenster (BFM) Therapy of Non-Hodgkin Lymphoma of Childhood: Significantly Higher Risk for Patients with Lymphoblastic Lymphoma Compared to Other NHL-Subtypes.

Olga Wachowski, Martin Zimmermann, Birgit Burkhardt et al. · Blood · 2005 · 10 citations

Medicine, Oncology, Pediatrics +12